TRAF6 and periodontitis: miR‐146a and miR‐155 may be novel biomarkers for periodontitis in both diabetic and nondiabetic patients. Additionally, miR‐126, by targeting TRAF6 and reducing inflammation in gingival fibroblasts under high glucose conditions, could serve as a potential therapeutic target for treating periodontitis in diabetic patients.